ClinicalTrials.gg
Sign In

Alopecia clinical trials

The registry lists 511 studies for Alopecia across more than 10 countries. 128 are recruiting or about to start. 439 of them are mainly about Alopecia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Alopecia Areata: 696 studies, 176 open.

ClinicalTrials.gov finds 742 studies for Alopecia. How that becomes 509 here

This page counts the studies the registry files under Alopecia, and those it files under no condition that list Alopeciathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 742Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −185Filed under a narrower condition, counted on its own pageAlopecia Areata 183 · Alopecia universalis 2
  3. −11List Alopecia as a condition, but the registry did not file them under itMost often written as “Chemotherapy-induced Alopecia” (4), “Frontal Fibrosing Alopecia” (3), and “Chemotherapy Induced Alopecia” (1). The registry filed them under other conditions only, most often Breast Neoplasms (5) and Lichen Planus (4).
  4. −37Match it another way22 name it in the title, 2 in a keyword, and 13 by a synonym or other text the search reads.
  5. 509The count on this page35 of them list Alopecia in their own words; the registry filed them under no condition.

Get an email when these change. Save the Alopecia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
244
Recruiting
74
Status unknown
56
Not yet recruiting
47
Active, not recruiting
35
Withdrawn
26

Phase

Phase 2
123
Phase 1
60
Phase 3
56
Phase 4
19
Early Phase 1
19

Where

United States
216
China
33
Spain
29
Egypt
25
Germany
24
Korea, Republic of
22

Who runs them

Applied Biology, Inc. (13) · Aderans Research Institute (11) · Suzhou Kintor Pharmaceutical Inc, (9) · Assiut University (8) · Allergan (7) · Cairo University (7) · University of Minnesota (6) · Northwestern University (6)

What is being tested here

Drugs under test in Alopecia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Minoxidil9827
Platelet rich plasma306
Finasteride216
JXL-069213
Baricitinib213
Triamcinolone Acetonide202
Triamcinolone202
PF-06651600135
KX-826124
Botulinum toxin type A113

Drug classes tested here JAK inhibitors 6 open · Tyrosine kinase inhibitors (TKIs) 6 open · 5-alpha reductase inhibitors 2 open · Corticosteroids 2 open

Coming up

23phase 3 studies under way
54studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 74 Alopecia studies recruiting now, 24 (32%) set no upper age limit and 46 (62%) stop at 75 or younger. 9 (12%) take children under 18. 17 (23%) are for women only and 17 (23%) for men only; 24 (32%) take healthy volunteers.

Recruiting studies that take each age, of 74
AgeWomenMen
104 (5%)4 (5%)
1844 (59%)46 (62%)
3053 (72%)54 (73%)
4056 (76%)55 (74%)
5055 (74%)52 (70%)
6544 (59%)38 (51%)
7531 (42%)25 (34%)
8525 (34%)20 (27%)

Across all 511 studies, recruiting or not: 66% stop at 75 or younger and 57% at 65; 8% take children; 23% are for women only and 28% for men only; 40% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Alopecia studies take

Of 41 phase 2 interventional studies under Alopecia, half reached primary completion within 13 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 110 mo5–57 · 33 studies——
Phase 213 mo9–24 · 41 studies12 mo9–18 · 25 studies—
Phase 319 mo12–59 · 28 studies——
Interventional, no phase12 mo6–27 · 146 studies9 mo5–20 · 61 studies13 mo8–46 · 85 studies
Observational20 mo5–38 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Stopped1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 511. Browse all 511 → or search them.